Viking Therapeutics, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost of Goods Sold | 0 | 94K | 114K | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 0 | -94K | -114K | 0 | 0 | 0 | 0 | 0 |
| R&D Expenses | 150.2M | 153.5M | 90.0M | 60.2M | 41.4M | 31.0M | 22.8M | 23.8M |
| Operating Expenses | 164.1M | 164.7M | 98.6M | 74.6M | 55.5M | 46.2M | 36.6M | 34.1M |
| Operating Income | -164.1M | -164.7M | -98.6M | -74.6M | -55.5M | -46.2M | -36.6M | -34.1M |
| Other Income / Gains | 5.8M | 7.1M | 7.8M | 9.0M | 9.8M | 10.8M | 11.6M | 11.8M |
| Net Income | -158.3M | -157.7M | -90.8M | -65.6M | -45.6M | -35.4M | -24.9M | -22.3M |
| EPS (Diluted) | -1.37 | -1.38 | -0.81 | -0.58 | -0.41 | -0.32 | -0.22 | -0.20 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General And Administrative Expenses | 14.0M | 11.3M | 8.6M | 14.4M | 14.1M | 15.3M | 13.8M | 10.3M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 14.0M | 11.3M | 8.6M | 14.4M | 14.1M | 15.3M | 13.8M | 10.3M |
| Other Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 164.1M | 164.7M | 98.6M | 74.6M | 55.5M | 46.2M | 36.6M | 34.1M |
| Interest Income | 5.8M | 7.0M | 7.8M | 9.0M | 9.9M | 10.8M | 11.5M | 11.8M |
| Interest Expense | 0 | 0 | 8K | 24K | 24K | 24K | 24K | 18K |
| Depreciation And Amortization | 0 | 94K | 114K | 112K | 111K | 110K | 87K | 75K |
| Ebitda | -164.1M | -164.7M | -98.4M | -74.5M | -55.4M | -46.1M | -36.5M | -34.0M |
| Ebitdaratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax | -158.3M | -157.7M | -90.8M | -65.6M | -45.6M | -35.4M | -24.9M | -22.3M |
| Income Before Tax Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Epsdiluted | -1.37 | -1.38 | -0.81 | -0.58 | -0.41 | -0.32 | -0.22 | -0.20 |
| Weighted Average Shs Out | 115.6M | 114.0M | 112.3M | 112.1M | 112.1M | 111.3M | 110.9M | 110.4M |
| Weighted Average Shs Out Dil | 115.6M | 114.0M | 112.3M | 112.1M | 112.1M | 111.3M | 110.9M | 110.4M |